CLASS I Drug recall · Reported 26 Aug 2020 · FDA Enforcement Report

Desmopressin Acetate Nasal Spray 10 mcg/ glass vial with spray cap recalled

Ferring Pharmaceuticals is recalling Desmopressin Acetate Nasal Spray 10 mcg/ glass vial with spray cap, distributed nationwide in the US. The recall was initiated on 21 Jul 2020 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: N14695P, N14695S, exp. date 08 2020; N15627G , exp. date 10 2020 N15627GA, exp. date 10 2020 P10422A, exp. date 01 2021 P10422AA, exp. date 01 2021 P10430G, exp. date 03 2021 P11319M, exp. date 01 2021 P12969H, exp. date 05 2021 P12969IR, exp. date 05 2021 P13216G, exp. date 05 2021 P13216P, exp. date 05 2021 R11842A, exp. date 03 2022 R11842S, exp. date 03 2022 R12630A, exp. date 05 2022 R13071H, exp. date 04 2022

Quantity recalled184,325 nasal sprays

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1505-2020
FDA event ID: 86066
Recalling firm: Ferring Pharmaceuticals, Parsippany, NJ
Classification: Class I
Status: Terminated
Recall initiated: 21 Jul 2020
FDA classified: 17 Aug 2020
Reported: 26 Aug 2020
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Potency & Assay
Drug class: Nasal Sprays

Timeline

21 Jul 2020	Recall initiated by company
17 Aug 2020	Classified by FDA	+27 days
26 Aug 2020	Published in enforcement report	+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Superpotent Drug

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05

Where it was distributed

Nationwide within the United States.

Nationwide

Questions about this recall

Why was it recalled?

Superpotent Drug

Which lots are affected?

Lot #: N14695P, N14695S, exp. date 08 2020; N15627G , exp. date 10 2020 N15627GA, exp. date 10 2020 P10422A, exp. date 01 2021 P10422AA, exp. date 01 2021 P10430G, exp. date 03 2021 P11319M, exp. date 01 2021 P12969H, exp. date 05 2021 P12969IR, exp. date 05 2021 P13216G, exp. date 05 2021 P13216P, exp. date 05 2021 R11842A, exp. date 03 2022 R11842S, exp. date 03 2022 R12630A, exp. date 05 2022 R13071H, exp. date 04 2022

Where was it sold?

Nationwide within the United States.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 86066

This product is part of a recall event; the main page for the event is Stimate (desmopressin acetate) Nasal Spray1.5 mg/mL glass recalled.

Reported	Class	Recall	Company	Reason	Where
26 Aug 2020	CLASS I	Stimate (desmopressin acetate) Nasal Spray1.5 mg/mL glass recalled	Ferring Pharmaceuticals	Potency & Assay	Nationwide
26 Aug 2020	CLASS I	Ddavp Nasal Spray (desmopressin acetate) 10 mcg recalled	Ferring Pharmaceuticals	Potency & Assay	Nationwide

More recalls from Ferring Pharmaceuticals

All 12

Reported	Class	Recall	Company	Reason	Where
5 Jul 2023Drug	CLASS II	Endometrin (progesterone) Vaginal Insert 100mg recalled	Ferring Pharmaceuticals	Sterility	Nationwide
7 Apr 2021Drug	CLASS II	Zoma-Jet 5 Demonstration Kit recalled by Ferring Pharmaceuticals	Ferring Pharmaceuticals	Other	Nationwide
7 Apr 2021Drug	CLASS II	Zoma-Jet 10 Demonstration Kit recalled by Ferring Pharmaceuticals	Ferring Pharmaceuticals	Other	Nationwide
17 Mar 2021Drug	CLASS III	Menopur 75 IU, (menotropins for injection) recalledMenopur	Ferring Pharmaceuticals	Potency & Assay	Nationwide
26 Aug 2020Drug	CLASS I	Ddavp Nasal Spray (desmopressin acetate) 10 mcg recalled	Ferring Pharmaceuticals	Potency & Assay	Nationwide

Other Desmopressin recalls

All 13

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Desmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalled	Apotex	Other	Nationwide
14 Dec 2022Drug	CLASS II	Desmopressin Acetate Tablet, 0.2 mg recalled by RemedyRepack	RemedyRepack	Potency & Assay	MI
7 Dec 2022Drug	CLASS II	Desmopressin Acetate Tablets 0.2mg recalled by Heritage PharmaceuticalsDesmopressin Acetate	Heritage Pharmaceuticals	Potency & Assay	Nationwide
6 Jul 2022Drug	CLASS II	Desmopressin Acetate Tablets, 0.2 mg recalled	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	TX
3 Mar 2021Drug	CLASS II	Desmopressin Acetate Injection USP, 4 mcg/mL Preserved Vial recalled	Teva Pharmaceuticals USA	Sterility	Nationwide